Background
==========

Many lumbar discectomy patients experience persistent or recurrent back or leg pain following surgery**.** Epidural steroids have been tried for many years as an adjunct to surgery in lumbar disc disease. Their use under these circumstances has been an attempt to reduce early postoperative inflammatory reaction and late scar formation in order to lessen postoperative pain. Ranguis et al. published a systematic review of 12 trials that examined the subject during 1992--2008 \[[@B1]\]. Four more trials have been published since \[[@B2]-[@B5]\]. In addition a survey of 112 Canadian neurosurgeons in 2009 showed that 61% of participants do not use epidural steroids in lumbar discectomy \[[@B6]\]. This would indicate that the clinical use of intraoperative steroids in lumbar discectomy is still a matter of controversy. Hence we feel justified in attempting to provide an updated examination of the literature on the matter.

This study is a descriptive review of the literature directed at examining the efficacy of intraoperative epidural steroids in lumbar discectomy. The objectives are to assess whether the use of steroids under such circumstances has significant effect on the severity of postoperative pain, the extent of analgesia consumption, the duration of hospital stay and the complication rates. We aim to achieve these goals by identifying and grouping all the significant differences relating to the outcome targets between patients who had intraoperative epidural steroids and controls as described by the authors.

Methods
=======

Eligibility criteria
--------------------

Our inclusion criteria were randomized controlled trials or cohort studies of patients who underwent lumbar discectomy and had steroids applied onto the epidural and exposed nerve root intraoperatively. The review was limited to studies that were published in the English language up to 2012. We included studies that provided sufficient data relating to all or part of the following: assessment scores for back pain (BP) and radicular leg pain (RLP) at defined times in the postoperative period, records of the extent of postoperative analgesia usage, the duration of hospital stay and complication rates. Suitable studies were included irrespective of whether the patients also received steroids intravenously, the discectomy techniques, the steroids dosage, the addition of another medication with the steroids and the inclusion in the trial of another group that received a non-steroidal medication. However, we excluded studies that were not published as full articles \[[@B7]\], studies that were not published in English \[[@B8]\], studies that reported patients in whom the steroids were injected intramuscularly (IM) \[[@B9]\] or intravenously (IV) \[[@B10],[@B11]\] without an epidural application. We also excluded studies of lumbar disc patients that had epidural steroids without surgery \[[@B12]\] and those in which the patients were treated with non-steroidal medications whether epidural \[[@B13],[@B14]\], IV \[[@B15]\] or IM \[[@B16]\].

Literature search
-----------------

The literature was systematically searched in April 2013 using a combination or part combination of the following terms: intraoperative, perioperative, epidural, steroids, methylprednisolone, depomedrol, lumbar disc surgery, discectomy for herniated lumbar disc, postoperative back pain and radicular leg pain and randomized controlled trials. The two investigators independently interrogated the literature using the databases PubMed, Medline and the Cochrane Central Register of Controlled Trials. The full texts of the potentially appropriate studies were retrieved and assessed.

Data extraction
---------------

Data were extracted from the included studies using a standardized form. The two investigators performed this independently and compared results to reduce extraction error. Missing data were referred to as not available. The following data were collected for each study: year of publication, number of patients treated with steroids, number of controls, total number of patients in the trial, dose of steroids and any additional medications given, method of pain score assessment, all recorded postoperative pain scores for BP and RLP and their timing, record of consumption of postoperative analgesia, duration of hospital stay and rates of complications such as infection and disc prolapse recurrence.

Outcome measures
----------------

Our outcome targets were: reduction in the postoperative pain scores for BP and RLP, reduction in the postoperative consumption of analgesia, reduction in the duration of hospital stay and no increase in complication rates.

Data analysis
-------------

As a result of the variation in the methods of pain scoring and timing assessments between the various series, the analysis was descriptive and focused on collecting all the significant and non-significant differences between the steroids and control groups as documented by the authors. The variation in the timing necessitated grouping the pain score assessments them into three postoperative stages: Early: from 0 to 2 weeks, Intermediate: from more than 2 week to 2 months and Late: from more than 2 months to 1 year after surgery. The evidence for or against each outcome target was considered strong or weak based on the number of supportive trials in comparison to the non-supportive trials, the size of their total patient population and their year of publication.

Assessment of methodological quality
------------------------------------

The two authors independently assessed the methodological quality of the reviewed articles based on a number of criteria including: randomization, blinding, withdrawals and dropouts, description of exposed and unexposed patient characteristics, comparability of cohorts, inclusion and exclusion criteria and definition and objectivity of outcomes. Each study was subjectively scored 0 or 1 for each of the mentioned criteria. Based on the score and on discussion between the two investigators if the scores varied, each study was graded for its perceived risk of bias as low risk, moderate risk or high risk.

Results
=======

Study selection and characteristics
-----------------------------------

The literature search yielded 16 studies of lumbar discectomy and intraoperative application of epidural steroids that were considered suitable for review. These included a total of 693 patients that had lumbar discectomy and received intraoperative epidural steroids and 617 controls \[[@B2]-[@B5],[@B17]-[@B28]\]. The steroids used were methylprednisolone 40 mg \[[@B3],[@B4],[@B17],[@B18],[@B21],[@B24],[@B26]\], methylprednisolone 80 mg \[[@B2],[@B5],[@B19],[@B20],[@B22],[@B23],[@B25],[@B27]\] and dexamethasone 16 mg \[[@B28]\]. The additional medications used included epidural fentanyl \[[@B5]\] and morphine \[[@B2],[@B23],[@B24]\] as well as IM bupivacaine \[[@B21],[@B25]\] and IM and IV methylprednisolone \[[@B20],[@B25]\]. The postoperative pain scores were assessed by Visual Analog Scale (VAS) \[[@B3]-[@B5],[@B18],[@B20]-[@B22]\], by McGill Pain Questionnaire (MPQ) \[[@B2],[@B23]\], by Aberdeen Back Pain Index (ABPI) \[[@B2]\] or by using a Numerical Rating Scale (NRS) from 0 to 10 \[[@B17],[@B19]\], from 0 to 3 \[[@B26]\] and from I to V \[[@B25]\]. Some authors did not state their methods of grading pain \[[@B24],[@B28]\].

Results of individual studies and risk of bias
----------------------------------------------

Table [1](#T1){ref-type="table"} summarizes all the significant and non-significant pain scores for treated patients and controls at the specified postoperative times as documented by the authors and the bias risk grade for each series. Analysis of the series reporting significant and non-significant reduction in pain scores during the early, intermediate and late postoperative stages is summarized in Table [2](#T2){ref-type="table"}. Analysis of the series reporting significant and non-significant reduction in the consumption of postoperative analgesia and in the hospital stay is summarized in Table [3](#T3){ref-type="table"}. None of trials reported a significant steroids-related increased rate of infection or recurrences. There were few reports of complications such as superficial wound infection, erythema, serous discharge, reoperation for recurrence and readmission for pain management that were observed nearly equally in both groups \[[@B2],[@B17],[@B20],[@B23]\].

###### 

Analysis of the significant and non-significant pain score recordings in the various series

  **Authors (Year) \[Reference\]**              **Patients numbers steroids/control**   **Bias risk grade**   **Significant pain score reduction**    **No significant pain score reduction**
  --------------------------------------------- --------------------------------------- --------------------- --------------------------------------- -------------------------------------------
  Diaz et al. (2012) \[[@B2]\]                  99/52\*                                 Low                   BP/RLP 1D,3D,7D                         BP/RLP 3 W, 6 W, 12 W, 6 M, 12 M
  Abrishamkar et al. (2011) \[[@B3]\]           22/22\*                                 Moderate              BP 6-12H and RLP 6H                     BP 18H, 24H, 2 W and RLP12H,18H, 24H, 2 W
  Modi et al. (2009) \[[@B4]\]                  29/28                                   Moderate              BP 2 W, 1 M                             BP 3 M, 6 M, 1Y
  Hackel et al. (2009) \[[@B5]\]                85/82                                   Moderate              BP/RLP 24H, 2-3D                        BP/RLP 4-5D, 12 M
  Rasmussen et al. (2008) \[[@B17]\]            100/100                                 Low                   RLP 2 M, 1Y                             BP 2 M, 1Y
  Lotfinia et al. (2007) \[[@B18]\]             50/50\*                                 Low                   Not available                           BP and RLP 24H, 48H, 72H, 96H
  Jirarattanaphochai et al. (2007) \[[@B19]\]   17/17                                   Low                   RLP 24H, 48H, 72H, 1 W                  BP 1 W, 1 M, 3 M and RLP 1 M, 3 M
  Lundin et al. (2003) \[[@B20]\]               38/42                                   Moderate              BP/RLP 2 W, 6 W, 12 W, 26 W, 52 W\*\*   BP/RLP 2 W, 6 W, 12 W, 26 W, 52 W\*\*\*
  Mirzai et al. (2002) \[[@B21]\]               22/22                                   Low                   Not available                           BP 1H, 3H, 6H, 12H
  Debi et al. (2002) \[[@B22]\]                 26/35                                   High                  BP 1D, 2D, 6D,14D                       BP 1Y and RLP 1D, 2D, 6D, 14D
  Hurlbert et al. (1999) \[[@B23]\]             30/30                                   Low                   BP/RLP 1D, 3 W, 6 W                     BP/RLP 12 W
  McNeill et al. (1995) \[[@B24]\]              56/25\*                                 Moderate              Not available                           Not available
  Glasser et al. (1993) \[[@B25]\]              12/10\*                                 High                  BP 1D and RLP 1D                        BP 1 W, 1 M and RLP 1 W, 1 M
  Lavyne et al. (1992) \[[@B26]\]               42/36                                   Moderate              Not available                           Not available
  Davis et al. (1990) \[[@B27]\]                43/43                                   High                  Not available                           Not available
  Foulkes et al. (1990) \[[@B28]\]              22/23                                   High                  Not available                           Not available

*Abbreviations*, *BP* Back pain, *RLP* Radicular leg pain, *H* Hour, *D* Day, *W* Week, *M* Month, *Y* Year.

\*Includes other group(s). \*\*Significant worst pain last week. \*\*\*Not Significant Pain just now.

###### 

Analysis of series reporting significant and non-significant reduction in the postoperative pain score

  **Series reporting**                                 **Early outcome**                 **Intermediate outcome**   **Late outcome**                                                                                                                                                                              
  ---------------------------------------------------- --------------------------------- -------------------------- -------------------------------- ----------------------------------------------------------- ----- -------------------------------------------- --------------------------------------- ----- ------
  Significant reduction in pain score                  **9**                             758                        2007                             **4**                                                       397   2006                                         **2**                                   280   2006
  \[[@B2]-[@B5],[@B19],[@B20],[@B22],[@B23],[@B25]\]                                                                \[[@B4],[@B17],[@B20],[@B23]\]                                                                     \[[@B17],[@B20]\]                                                                          
  Non-significant reduction in pain score              **2**                             194                        2005                             **3**                                                       267   2007                                         **6**                                   580   2008
  \[[@B18],[@B21]\]                                                                                                 \[[@B2],[@B19],[@B25]\]                                                                            \[[@B2],[@B4],[@B5],[@B19],[@B22],[@B23]\]                                                 
  No pain score                                        **5**                             519                        1992                             **9**                                                       807   2002                                         **8**                                   611   1994
                                                       \[[@B17],[@B24],[@B26]-[@B28]\]                                                               \[[@B3],[@B5],[@B18],[@B21],[@B22],[@B24],[@B26]-[@B28]\]                                                      \[[@B3],[@B18],[@B21],[@B24]-[@B28]\]          

###### 

Analysis of series regarding reduction in postoperative analgesia and hospital stay

  **Authors (Year) \[Reference\]**             **Total patients**   **Reduction in postoperative analgesia**   **Reduction in hospital stay (average in days)**
  -------------------------------------------- -------------------- ------------------------------------------ --------------------------------------------------
  Diaz et al. (2012) \[[@B2]\]                 201                  Significant                                Not significant
  Abrishamkr et al. (2011) \[[@B3]\]           66                   Not available                              Not available
  Modi et al. (2009) \[[@B4]\]                 57                   Not available                              Not available
  Hackel et al. (2009) \[[@B5]\]               167                  Not available                              Significant (4.5 vs. 5.2)
  Rasmussen et al. (2008) \[[@B17]\]           200                  Not available                              Significant (6 vs. 8 )
  Lotfinia et al. (2007) \[[@B18]\]            150                  Not available                              Not available
  Jirarattanaphchai et al. (2007) \[[@B19]\]   34                   Significant                                Not available
  Lundin et al. (2003) \[[@B20]\]              80                   Not available                              Significant (1.7 vs. 2.3)
  Mirzai et al. (2002) \[[@B21]\]              44                   Significant                                Not available
  Debi et al. (2002) \[[@B22]\]                61                   Not available                              Not significant
  Hurlbert et al. (1999) \[[@B23]\]            60                   Significant                                Not significant
  McNeill et al. (1995) \[[@B24]\]             110                  Not significant                            Not available
  Glasser et al. (1993) \[[@B25]\]             32                   Significant                                Significant (1.4 vs. 4)
  Lavyne et al. (1992) \[[@B26]\]              78                   Not significant                            Not significant
  Davis et al. (1990) \[[@B27]\]               86                   Significant                                Significant (2.7 vs. 4.4)
  Foulkes et al. (1990) \[[@B28]\]             45                   Significant                                Significant (6.4 vs. 8.7)

Discussion
==========

Good pain control following surgery for degenerative lumbar disease is important as it is associated with a decrease in the incidence of postoperative complications \[[@B1]\]. Pain following disc surgery is related to a number of factors that include the inflammatory cascade which is triggered by tissue trauma and direct manipulation of the nerve root. Intraoperative epidural steroids have been used as an adjuvant pain therapy in lumbar disc surgery. It is thought that they reduce postoperative pain by suppressing mediators of pain and inflammation such as prostaglandins, leukotrienes, bradykinin and histamine \[[@B2],[@B28]\]. It is also hypothesized that steroids decrease pain by preventing of epidural fibrosis and limiting the degree of scar formation after lumbar surgery \[[@B2]\]. The latter suggestion however was not supported by the study of Hackel et al. who reported that the application of epidural steroids was not associated with lower incidence of scar formation or failed back syndrome \[[@B5]\].

Intraoperative epidural steroids have been advocated for more than two decades \[[@B27],[@B28]\] and despite the publication of a number of trials their use is still considered a matter of debate. Ranguis et al. published the first systematic review of 12 trials on the topic in 2010. However, their meta-analysis of data related to back pain was limited to 7 trials, data related to radicular pain was limited to 5 trials, data related to postoperative consumption of analgesia was limited to 7 trials and data related to length of hospital stay was limited to 4 trials \[[@B1]\]. This study aimed at assessing the collective experience of all the 16 relevant trials and because of the heterogeneity of the reported data the review was descriptive.

Our review shows that the trials which did not report pain scores compared to those which reported significant and non-significant recordings at the various postoperative stages were relatively older (median publication 1992 vs. 2005, 2007 for early outcome, 2002 vs. 2006, 2007 for intermediate outcome and 1994 vs. 2006, 2008 for late outcome) (Table [2](#T2){ref-type="table"}).

In the trials that examined the early outcome for pain scores (Table [2](#T2){ref-type="table"}), a significant reduction was observed in 9 out of 11 trials (82%), that had a total patient population of 758 out of 952 (80%) and were relatively more recent compared to those reporting a non-significant reduction (median publication 2007 vs. 2005). This would indicate that the evidence in support of intraoperative epidural steroids reducing early postoperative pain (within the first two weeks) can be considered relatively strong.

In the trials that examined intermediate pain score outcome (Table [2](#T2){ref-type="table"}), a significant reduction was observed in 4 out of 7 trials (57%), that had a total patient population of 397 out of 664 (60%) and were of comparable publication year to those reporting a non-significant reduction (median publication 2006 vs. 2007). This would indicate that the evidence in support of intraoperative epidural steroids reducing intermediate postoperative pain (from two weeks to two months) can be considered relatively weak.

In the trials that examined late pain score outcome (Table [2](#T2){ref-type="table"}), a non-significant reduction was observed in 6 out of 8 trials (75%), that had a total patient population 580 out of 860 (67%) and were relatively more recent compared to those reporting a significant reduction (median publication 2008 vs. 2006). This would indicate that the evidence in support of intraoperative epidural steroids not reducing late postoperative pain (from 2 months to one year) can be considered relatively strong.

In the trials that examined the consumption of postoperative analgesia (Table [3](#T3){ref-type="table"}), a significant reduction was observed in 7 out of 9 trials (77%) that had a total patient population of 502 out of 690 (73%) and were relatively more recent compared to those reporting a non-significant reduction (median publication 1999 vs. 1994). This would indicate that the evidence for intraoperative epidural steroids reducing the consumption of postoperative analgesia can be considered relatively strong.

In the trials that examined the duration of hospital stay (Table [3](#T3){ref-type="table"}), a significant reduction was observed in 6 out of 10 trials (60%) that had a total patient population of 610 out of 1010 (60%) and were relatively older than those reporting a non-significant reduction (median publication 1998 vs. 2001). This would indicate that the evidence for intraoperative epidural steroids reducing the duration of hospital stay can be considered relatively weak.

Our review also endorses that the use of intraoperative steroids is not associated with an increased risk of complications such as infection and prolapse recurrence. Lowell et al. reported three cases of epidural abscess that occurred following the use of epidural steroids in 31 micro discectomy patients \[[@B29]\]. They suggested that the infection may have been related to the use of epidural steroids. Their findings however have not been substantiated by others reporters or by our review.

Our results support the conclusions made by Ranguis et al. that intraoperative epidural steroids decrease pain in the short term and reduce the postoperative consumption of analgesia \[[@B1]\]. However it did not support their observation that steroids use is associated with a significant shortening of hospital stay. The latter could be because they based their conclusion on the data of 4 trials only \[[@B1]\].

Study limitations
-----------------

There are several important limitations in the available literature on intraoperative epidural steroids in lumbar disc surgery. This is mainly because the various studies were heterogeneous with regards to the outcome measures, the method of pain assessment, the timing and location of the pain assessed, the surgical technique, the steroid dosage, the addition of other medication, the reporting of all relevant data and the risk of bias. As a result we elected not to address the matter of timing of return to work and quality of life in this study.

Conclusions
===========

The considerable variation between the trials makes it difficult to make undisputed conclusions. Nevertheless, based on the assessment of 16 intraoperative epidural steroids trials it appears that there is relatively strong evidence that they are effective in reducing pain in the early stage and reducing the consumption of postoperative analgesia without an increased risk of complications. There is also relatively strong evidence that they are ineffective in reducing pain in the late stage and in reducing the duration of hospital stay. The evidence for their effectiveness in reducing pain in the intermediate stage is considered relatively weak. Our findings support the use of epidural steroids in lumbar discectomy. However, there is a definite need for a large multicenter trial with validated outcome measures that are recorded at fixed time intervals.

Abbreviations
=============

BP: Back pain; RLP: Radicular leg pain; IM: Intramuscularly; IV: Intravenously; VAS: Visual analog scale; MPQ: McGill pain questionnaire; ABPI: Aberdeen back pain index; NRS: Numerical rating scale; H: Hour; D: Day; W: Week; M: Month; Y: Year.

Competing interests
===================

The authors declare that they have no competing interests.

Authors' contributions
======================

BAJ: Data acquisition, analysis and writing of manuscript. ABJ: Study conception, design, data acquisition, analysis and manuscript revision and approval. Both authors read and approved the final manuscript.

Pre-publication history
=======================

The pre-publication history for this paper can be accessed here:

<http://www.biomedcentral.com/1471-2474/15/146/prepub>
